- Home
- ACCO vs CRVS Comparison
ACCO vs CRVS Comparison
Compare ACCO & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACCO
- CRVS
- Stock Information
- Founded
- ACCO 1893
- CRVS 2014
- Country
- ACCO United States
- CRVS United States
- Employees
- ACCO N/A
- CRVS N/A
- Industry
- ACCO Publishing
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- ACCO Consumer Discretionary
- CRVS Health Care
- Exchange
- ACCO Nasdaq
- CRVS Nasdaq
- Market Cap
- ACCO 353.3M
- CRVS 305.4M
- IPO Year
- ACCO N/A
- CRVS 2016
- Fundamental
- Price
- ACCO $4.00
- CRVS $5.75
- Analyst Decision
- ACCO Buy
- CRVS Strong Buy
- Analyst Count
- ACCO 1
- CRVS 4
- Target Price
- ACCO $6.00
- CRVS $15.00
- AVG Volume (30 Days)
- ACCO 530.2K
- CRVS 518.7K
- Earning Date
- ACCO 07-31-2025
- CRVS 08-07-2025
- Dividend Yield
- ACCO 7.46%
- CRVS N/A
- EPS Growth
- ACCO N/A
- CRVS N/A
- EPS
- ACCO 0.49
- CRVS N/A
- Revenue
- ACCO $1,581,200,000.00
- CRVS N/A
- Revenue This Year
- ACCO N/A
- CRVS N/A
- Revenue Next Year
- ACCO $2.11
- CRVS N/A
- P/E Ratio
- ACCO $8.21
- CRVS N/A
- Revenue Growth
- ACCO N/A
- CRVS N/A
- 52 Week Low
- ACCO $3.32
- CRVS $2.54
- 52 Week High
- ACCO $6.44
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- ACCO 59.22
- CRVS 65.10
- Support Level
- ACCO $3.90
- CRVS $5.28
- Resistance Level
- ACCO $4.01
- CRVS $5.64
- Average True Range (ATR)
- ACCO 0.10
- CRVS 0.30
- MACD
- ACCO 0.01
- CRVS 0.03
- Stochastic Oscillator
- ACCO 79.91
- CRVS 77.70
About ACCO Acco Brands Corporation
ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).